Related Experiment Videos
Point mutation and polymorphism in Duchenne/Becker muscular dystrophy (D/BMD) patients
L S Chaturvedi1, M Mukherjee, S Srivastava
1Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Experimental & Molecular Medicine
|January 25, 2002
Summary
Researchers identified a novel mutation in the dystrophin gene causing Duchenne and Becker muscular dystrophies (D/BMD). This specific C2268T substitution offers a new avenue for carrier detection and prenatal diagnosis in affected families.
Area of Science:
- Genetics
- Molecular Biology
- Neuromuscular Disorders
Background:
- Duchenne and Becker muscular dystrophies (D/BMD) result from mutations in the dystrophin gene.
- While large deletions/duplications are common, point mutations are harder to detect due to the gene's size.
- Accurate mutation detection is crucial for diagnosis and genetic counseling.
Purpose of the Study:
- To detect point mutations in the dystrophin gene in D/BMD patients negative for large deletions.
- To identify novel mutations and assess their diagnostic utility.
Main Methods:
- Analysis of 50 D/BMD patient DNA samples lacking intragenic deletions.
- Utilized single-stranded conformation analysis (SSCA) and heteroduplex analysis (HA).
- Sequencing of PCR-amplified products from samples showing mobility shifts.
Main Results:
- SSCA and HA identified mobility shifts in three patients (one BMD, two DMD/BMD).
- A novel C2268T exonic substitution was found in one patient, changing Thr687 to Met.
- This novel mutation was confirmed and added to the Leiden Muscular Dystrophy database.
Conclusions:
- A novel dystrophin gene mutation (C2268T) was identified in a D/BMD patient.
- This mutation segregates with the disease phenotype, enabling carrier and prenatal diagnosis.
- The findings highlight the importance of screening for point mutations in D/BMD diagnostics.